🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 15 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/08/2020 | 110,02 | 110,11 | 107,02 | 107,12 | -3,43% | 2,81% | 307.600 |
| 18/08/2020 | 111,15 | 111,30 | 109,10 | 110,93 | +0,16% | 1,98% | 250.900 |
| 17/08/2020 | 109,27 | 111,32 | 108,03 | 110,75 | +1,17% | 3,01% | 206.400 |
| 14/08/2020 | 109,45 | 109,91 | 108,71 | 109,47 | +0,08% | 1,10% | 169.900 |
| 13/08/2020 | 110,71 | 111,00 | 108,44 | 109,38 | -1,03% | 2,31% | 204.100 |
| 12/08/2020 | 109,66 | 110,82 | 108,89 | 110,52 | +1,26% | 1,76% | 243.300 |
| 11/08/2020 | 111,01 | 111,93 | 108,93 | 109,15 | -1,60% | 2,70% | 185.000 |
| 10/08/2020 | 112,41 | 112,96 | 110,83 | 110,93 | -1,65% | 1,89% | 153.700 |
| 07/08/2020 | 112,80 | 113,27 | 111,64 | 112,79 | +0,53% | 1,45% | 255.200 |
| 06/08/2020 | 113,30 | 113,55 | 111,69 | 112,20 | -0,77% | 1,64% | 179.400 |
| 05/08/2020 | 115,34 | 115,34 | 112,69 | 113,07 | -0,89% | 2,30% | 212.400 |
| 04/08/2020 | 115,87 | 116,12 | 113,45 | 114,09 | -1,99% | 2,30% | 305.100 |
| 03/08/2020 | 113,06 | 116,80 | 113,06 | 116,41 | +4,43% | 3,31% | 332.700 |
| 31/07/2020 | 113,42 | 113,42 | 110,30 | 111,47 | -1,79% | 2,75% | 331.100 |
| 30/07/2020 | 111,31 | 114,46 | 111,29 | 113,50 | +0,68% | 2,85% | 330.100 |
| 29/07/2020 | 115,99 | 120,41 | 111,40 | 112,73 | -0,38% | 7,77% | 652.700 |
| 28/07/2020 | 114,30 | 114,59 | 112,93 | 113,16 | -1,33% | 1,45% | 225.500 |
| 27/07/2020 | 112,68 | 115,03 | 112,00 | 114,68 | +2,16% | 2,69% | 275.200 |
| 24/07/2020 | 113,43 | 115,51 | 111,18 | 112,26 | -1,93% | 3,82% | 289.800 |
| 23/07/2020 | 113,96 | 116,71 | 113,66 | 114,47 | +0,83% | 2,68% | 305.600 |
| 22/07/2020 | 113,43 | 114,41 | 112,21 | 113,53 | +0,23% | 1,94% | 262.200 |
| 21/07/2020 | 115,28 | 115,91 | 113,17 | 113,27 | -1,79% | 2,38% | 326.000 |
| 20/07/2020 | 117,99 | 118,54 | 113,99 | 115,34 | -1,59% | 3,86% | 595.300 |
| 17/07/2020 | 116,63 | 117,94 | 116,00 | 117,20 | +1,07% | 1,66% | 454.100 |
| 16/07/2020 | 120,57 | 120,57 | 115,85 | 115,96 | -4,27% | 3,91% | 378.100 |
| 15/07/2020 | 121,29 | 121,51 | 119,29 | 121,13 | +2,33% | 1,83% | 318.500 |
| 14/07/2020 | 116,83 | 118,43 | 115,47 | 118,37 | +2,09% | 2,53% | 288.000 |
| 13/07/2020 | 118,00 | 119,39 | 115,92 | 115,95 | -1,27% | 2,94% | 319.600 |
| 10/07/2020 | 117,37 | 117,65 | 116,12 | 117,44 | +0,44% | 1,30% | 255.400 |
| 09/07/2020 | 117,62 | 118,52 | 115,92 | 116,92 | -0,73% | 2,21% | 485.600 |